NCT00264251View on ClinicalTrials.gov

Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

August 31, 2007

Conditions
HIV InfectionsInsulin ResistanceObesity
Interventions
BEHAVIORAL

Weight loss through diet and exercise

DRUG

Rosiglitazone insulin sensitizing agent

Trial Locations (1)

10025

St. Luke's-Roosevelt Hospital Center, New York

All Listed Sponsors
lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT00264251 - Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance | Biotech Hunter | Biotech Hunter